The following drugs should be changed to oral (PO) therapy as soon as clinically feasible and if clinically appropriate
The suggested PO adult doses assume normal renal function
IV Adult Dose | PO Adult Dose |
---|---|
Ampicillin 1 g q6h | Amoxicillin 500 mg q8h |
IV Adult Dose | PO Adult Dose |
---|---|
Azithromycin 500 mg q24h | Azithromycin 250-500 mg q24h |
IV Adult Dose | PO Adult Dose |
---|---|
Cefazolin 1 g q8h | Cephalexin 500 mg q6h |
IV Adult Dose | PO Adult Dose |
---|---|
Ceftazidime 1-2 g q8h | Ciprofloxacin 500-750 mg q12h |
IV Adult Dose | PO Adult Dose |
---|---|
Ceftriaxone 1 g q24h | Amoxicillin/Clavulanate 875 mg q12h OR Cefuroxime Axetil 500 mg q12h |
IV Adult Dose | PO Adult Dose |
---|---|
Cefuroxime 750 mg q8h | Cefuroxime Axetil 500 mg q12h |
IV Adult Dose | PO Adult Dose |
---|---|
Ciprofloxacin 400 mg q12h | Ciprofloxacin 500-750 mg q12h |
IV Adult Dose | PO Adult Dose |
---|---|
Clindamycin 300-600 mg q8h | Clindamycin 300-450 mg q6h |
IV Adult Dose | PO Adult Dose |
---|---|
Fluconazole 400 mg daily | Fluconazole 400 mg daily |
IV Adult Dose | PO Adult Dose |
---|---|
Levofloxacin 500-750 mg q24h | Levofloxacin 500-750 mg q24h |
IV Adult Dose | PO Adult Dose |
---|---|
Metronidazole 500 mg q8h | Metronidazole 500 mg q8h |
IV Adult Dose | PO Adult Dose |
---|---|
Piperacillin/Tazobactam q6-8h | Amoxicillin/Clavulanate 875 mg q12h (if no Pseudomonas) OR Ciprofloxacin (if Pseudomonas) |
January 2023 TBRHSC ASP Pocket Card